GENF (GENF) News
Track canonical SquawkNews coverage tagged to GENF, GENF. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Genflow Biosciences says Slab clinical trial meets primary endpoint
Genflow Biosciences PLC says its Slab clinical trial met the primary endpoint.
EQUITY | Sep 08, 2026, 06:51 AM UTC
M
Genflow Biosciences reports primary endpoint in SLAB clinical trial
Genflow Biosciences PLC said it has a primary endpoint in its SLAB clinical trial, in an RNS published 08 September 2026.
EQUITY | Sep 08, 2026, 06:00 AM UTC
L
Genflow Biosciences PLC Announces Primary Endpoint in SLAB Clinical Trial Met
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT
EQUITY | Sep 08, 2026, 06:00 AM UTC
L
Genflow Biosciences appoints ON365 as investor relations adviser
Genflow Biosciences PLC appointed ON365 Partners Inc. as its investor relations adviser, effective for company IR activities.
EQUITY | Sep 07, 2026, 06:00 AM UTC